FLCN Gene

What the FLCN Gene Means in Everyday Language

The FLCN gene, also known as the folliculin gene, is a part of your body’s genetic code that helps control how cells grow and work. Normally, it acts as a tumor suppressor, which means it helps prevent cells from growing out of control. When the FLCN gene has a mutation—a change in its DNA—it may not work properly. This can lead to abnormal cell growth, which increases the risk of certain health problems.

Why the FLCN Gene Matters in Cancer Care

Mutations in the FLCN gene cause a rare inherited condition called Birt-Hogg-Dubé syndrome (BHD). People with BHD often develop small, non-cancerous skin bumps called fibrofolliculomas, usually on the face, neck, and chest. More importantly, BHD raises the risk of kidney tumors, some of which can be cancerous. It also affects the lungs, where cysts may form and sometimes cause a lung to collapse (pneumothorax). Because of these risks, doctors recommend regular imaging tests like ultrasounds or CT scans to monitor kidney and lung health closely. Early detection of kidney tumors can help with timely treatment and better outcomes.

What Patients Might See or Hear About the FLCN Gene

If you or a family member is diagnosed with a mutation in the FLCN gene, you might hear about Birt-Hogg-Dubé syndrome and its related symptoms. You may notice small, raised skin bumps that are harmless but visible. Your healthcare team will likely discuss the increased risk for kidney tumors and lung cysts. Genetic counseling is often offered to explain what the mutation means for you and your family, including the chance that relatives might also carry the mutation. Regular check-ups and imaging tests will be recommended to watch for any changes in the kidneys or lungs.

Where You Might See the Term FLCN Gene

The term FLCN gene may appear in genetic test results, medical records, or treatment plans related to kidney cancer risk or Birt-Hogg-Dubé syndrome. It can come up during genetic counseling sessions or family history discussions. Understanding this term helps patients and caregivers know why ongoing monitoring and family testing might be important.

What the FLCN Gene Mutation Does Not Automatically Mean

Having a mutation in the FLCN gene or a diagnosis of Birt-Hogg-Dubé syndrome does not mean you currently have cancer or that you will definitely develop it. The skin bumps associated with this syndrome are benign and do not turn into cancer. The gene mutation signals an increased risk, so careful monitoring is recommended to catch any problems early. This helps avoid unnecessary worry and supports timely care if needed.

How Doctors Use Information About the FLCN Gene

Doctors use knowledge about the FLCN gene mutation to guide care for patients with Birt-Hogg-Dubé syndrome. This includes recommending regular imaging tests to monitor the kidneys and lungs, watching for tumors or cysts. If kidney tumors or lung problems develop, they are treated according to standard medical care. Genetic counseling helps patients understand the inherited nature of the syndrome and decide about testing for family members. This information helps personalize care and prevention strategies.

Next Steps and Safety Information

This information is educational and does not replace medical advice. If the FLCN gene or Birt-Hogg-Dubé syndrome is mentioned in your medical care, the best next step is to talk with your healthcare team. They can explain what it means for your specific situation, discuss genetic testing options, and help plan monitoring or treatment. Understanding your genetic risk can empower you to take part in your care and support your family’s health.